Novartis Pharmaceuticals Settles $390MM FCA Allegations
Shared post from the Dorsey FCA NOW blog, December 3, 2015.
Author: Kristin Zinsmaster
Kristin is an associate in Dorsey’s Trial Group. Her practice focuses on government enforcement, internal investigations, securities litigation, and shareholder derivative claims. She is particularly experienced in matters involving federal securities law, the Minnesota and Delaware business codes, financial services regulation, FDA compliance, and federal criminal law. Kristin represents clients in federal and state court as well as in investigations, large and small. She routinely—and successfully—manages pre-trial motion practice and discovery in large-scale litigation.
